A detailed history of Quantamental Technologies LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Quantamental Technologies LLC holds 10,156 shares of IBRX stock, worth $27,116. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,156
Previous 10,456 2.87%
Holding current value
$27,116
Previous $29,000 41.38%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$1.29 - $3.1 $387 - $930
-300 Reduced 2.87%
10,156 $17,000
Q2 2023

Aug 14, 2023

SELL
$1.53 - $6.41 $1,989 - $8,333
-1,300 Reduced 11.06%
10,456 $29,000
Q1 2023

May 15, 2023

SELL
$1.35 - $4.78 $2,698 - $9,555
-1,999 Reduced 14.53%
11,756 $21,000
Q4 2022

Feb 14, 2023

BUY
$4.35 - $6.77 $59,834 - $93,121
13,755 New
13,755 $69,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.07B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.